VP, Head of Late Clinical Development - Oncology

Working with Us
Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us.

Position Title: Vice President, Head of Late Clinical Development - Oncology

Position Summary
The VP, Head of Late Clinical Development – Oncology, is a senior executive level role considered critical to the sustainability and success of the BMS R&D pipeline. This role reports to the Head of Late Development HOCT (Hematology, Oncology, Cell Therapy) with responsibility for the clinical development strategy across the entire BMS Oncology portfolio. This also includes oversight of clinical monitoring, interpretation and analysis of all clinical trials and protocols in late-stage development, life cycle management as well as all global clinical development components of regulatory documents. Preferred locations are New Jersey, USA or Boudry, Switzerland.

Key Responsibilities
•    Serving as a talent champion for BMS, and building, recruiting, developing, and retaining a world class organization of oncology and immuno- oncology clinical development professionals
•    Creating and articulating a vision for an innovative and expert Clinical Development organization that enables the design and execution of clinical research plans with both speed and rigor across a broad oncology/immune oncology portfolio
•    Supervising the development, clinical components of execution, clinical monitoring, interpretation and analysis of all clinical trials and protocols in late-stage development and life cycle management (with registrational intent)
•    Interfacing with key thought leaders and experts in oncology and immuno- oncology drug development
•    Managing all clinical components of regulatory documents, including filings for initial registration and LCM indications
•    Serving as the organization’s senior expert on oncology clinical development and partnering strategically with the Early Clinical Development team to ensure a seamless transition from Phase 1 to Phase 2
•    Partnering with key matrix stakeholders to advise the Head of Integrated Oncology on critical development decisions and oncology portfolio management.
•    Providing strategic insight and clinical functional expertise to our business development group; accountable for clinical development planning and clinical due diligence for all post proof concept assets under consideration for in-licensing or acquisition
•    Representing BMS in critical discussions with health authorities in the interpretation of clinical data, clinical trial design experiments, and safety and efficacy profiles of our compounds
•    Effectively collaborating with global cross functional matrix leaders within the organization, while supporting and enhancing the matrix structure of Development Teams
•    Developing and promoting a workplace culture that values diversity of thought, promotes integrity and creates an atmosphere that supports coaching and fosters accountability

Qualifications & Experience
•    MD required (Board Certification in Oncology preferred)
•    Significant clinical research and drug development expertise and leadership experience (10+ years) in oncology 
•    Deep understanding of early stage through late-stage drug development issues and challenges, as well as extensive experience designing and conducting innovative Phase 2 and Phase 3 clinical trials within related areas of focus
•    Significant successful global drug filing expertise and regulatory interaction experience (i.e. NDA, ODAC, oral explanation, etc.).
•    Knowledge, experience and successful professional relationships with external oncology thought leaders.
•    Successful experience building, leading and motivating teams of clinical research professionals, including MDs, PhDs, and/or PharmDs.
•    Documented success navi